SAG
GILD icon

SageView Advisory Group’s Gilead Sciences GILD Stock Holding History

SageView Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
8,588
-629
-7% -$82.9K 0.04% 238
2026
Q1 		$1.28M Sell
9,217
-13,264
-59% -$1.86M 0.05% 204
2025
Q4 		$2.76M Sell
22,481
-1,459
-6% -$177K 0.09% 125
2025
Q3 		$2.66M Buy
23,940
+14,715
+160% +$1.67M 0.09% 134
2025
Q2 		$1.04M Buy
9,225
+2,425
+36% +$258K 0.04% 234
2025
Q1 		$762K Sell
6,800
-377
-5% -$38.9K 0.03% 266
2024
Q4 		$663K Sell
7,177
-369
-5% -$33.2K 0.03% 293
2024
Q3 		$633K Sell
7,546
-1,071
-12% -$81.7K 0.03% 259
2024
Q2 		$591K Buy
+8,617
New +$575K 0.03% 307
2024
Q1 		– Sell
-20,719
Closed -$1.63M – 602
2023
Q4 		$1.63M Buy
20,719
+1,791
+9% +$139K 0.07% 178
2023
Q3 		$1.42M Sell
18,928
-74
-0.4% -$5.69K 0.08% 159
2023
Q2 		$1.46M Buy
19,002
+752
+4% +$60K 0.08% 165
2023
Q1 		$1.51M Buy
18,250
+13,632
+295% +$1.13M 0.1% 140
2022
Q4 		$396K Buy
+4,618
New +$366K 0.03% 276

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SageView Advisory Group's GILD Position: Q2 2026 in Review

SageView Advisory Group reduced its Gilead Sciences (GILD) stake by 6.8% in Q2 2026, selling an estimated $82.9K and leaving 8,588 shares worth $1.09M. The position accounts for 0.04% of the portfolio, ranked #238.

SageView Advisory Group first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.76M in Q4 2025. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • SageView Advisory Group held 8,588 shares of Gilead Sciences worth $1.09M as of Q2 2026.
  • SageView Advisory Group sold 629 Gilead Sciences shares in Q2 2026, an estimated $82.9K.
  • Gilead Sciences made up 0.04% of SageView Advisory Group's portfolio in Q2 2026, its #238 holding.
  • SageView Advisory Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • SageView Advisory Group's Gilead Sciences position peaked at $2.76M in Q4 2025.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.